Knowledge-based dose prediction models to inform gynecologic brachytherapy needle supplementation for locally advanced cervical cancer - PubMed (original) (raw)

. 2021 Nov-Dec;20(6):1187-1199.

doi: 10.1016/j.brachy.2021.07.001. Epub 2021 Aug 13.

Jyoti Mayadev 1, Kelly Kisling 1, Derek Brown 1, Daniel Scanderbeg 1, Xenia Ray 1, Katherina Cortes 1, Aaron Simon 1, Catheryn M Yashar 1, John P Einck 1, Loren K Mell 1, Kevin L Moore 1, Sandra M Meyers 2

Affiliations

Free article

Knowledge-based dose prediction models to inform gynecologic brachytherapy needle supplementation for locally advanced cervical cancer

Karoline Kallis et al. Brachytherapy. 2021 Nov-Dec.

Free article

Abstract

Purpose: The use of interstitial needles, combined with intracavitary applicators, enables customized dose distributions and is beneficial for complex cases, but increases procedure time. Overall, applicator selection is not standardized and depends on physician expertise and preference. The purpose of this study is to determine whether dose prediction models can guide needle supplementation decision-making for cervical cancer.

Materials and methods: Intracavitary knowledge-based models for organ-at-risk (OAR) dose estimation were trained and validated for tandem-and-ring/ovoids (T&R/T&O) implants. Models were applied to hybrid cases with 1-3 implanted needles to predict OAR dose without needles. As a reference, 70/67 hybrid T&R/T&O cases were replanned without needles, following a standardized procedure guided by dose predictions. If a replanned dose exceeded the dose objective, the case was categorized as requiring needles. Receiver operating characteristic (ROC) curves of needle classification accuracy were generated. Optimal classification thresholds were determined from the Youden Index.

Results: Needle supplementation reduced dose to OARs. However, 67%/39% of replans for T&R/T&O met all dose constraints without needles. The ROC for T&R/T&O models had an area-under-curve of 0.89/0.86, proving high classification accuracy. The optimal threshold of 99%/101% of the dose limit for T&R/T&O resulted in classification sensitivity and specificity of 78%/86% and 85%/78%.

Conclusions: Needle supplementation reduced OAR dose for most cases but was not always required to meet standard dose objectives, particularly for T&R cases. Our knowledge-based dose prediction model accurately identified cases that could have met constraints without needle supplementation, suggesting that such models may be beneficial for applicator selection.

Keywords: Brachytherapy; Cervix cancer; Dose prediction; Needle supplementation; knowledge-based.

Copyright © 2021 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources